Galmed Pharmaceuticals Provides Business Update and Reports Third Quarter 2018 Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. META
3. ABBV
4. SPY
5. FDX
6. IBM
7. MU
8. PFE
9. AWK
10. ACN

Go back to Galmed Pharmaceuticals Provides Business Update and Reports Third Quarter 2018 Financial Results

Galmed Pharma (GLMD) Tops Q3 EPS by 19c

November 5, 2018 7:07 AM EST

Galmed Pharma (NASDAQ: GLMD) reported Q3 EPS of $0.05, $0.19 better than the analyst estimate of ($0.14).

For earnings history and earnings-related data on Galmed Pharma (GLMD) click here.

... More